Trastuzumab for Salivary Gland Cancer User Reviews
Brand names: Herceptin, Trazimera, Ogivri, Ontruzant, Kanjinti, Hercessi, Herzuma
Are you taking this medicine?
Your review helps others make informed decisions.Reviews may be edited to correct grammar/spelling or remove inappropriate content. Reviews appearing to come from parties with a vested interest are not published. This information is not intended to endorse any medication and should not replace the expertise and judgment of healthcare professionals.
More about trastuzumab
- Check interactions
- Compare alternatives
- Reviews (12)
- Side effects
- Dosage information
- During pregnancy
- Support group
- Drug class: HER2 inhibitors
- Breastfeeding
- En español
Patient resources
- Trastuzumab drug information
- Trastuzumab (Advanced Reading)
- Trastuzumab-anns (Advanced Reading)
- Trastuzumab-dkst (Advanced Reading)
- Trastuzumab-dttb (Advanced Reading)
Other brands
Herceptin, Trazimera, Ogivri, Ontruzant, ... +3 more
Professional resources
Other brands
Herceptin, Trazimera, Ogivri, Ontruzant, ... +3 more
"My husband has been on Herceptin for his salivary gland cancer for 2 years. The fight to keep him on it has been harrowing as it is only formally approved for breast cancer. I truly believe it saved his life. He tested HER-2/neu positive (3), which is normally located in the breast. Dr. Posner (Dana-Farber in Boston) recommended a course of treatment that included Herceptin. His PET scans have now been clear, and treatment can stop at the end of August. More needs to be done to allow life-saving treatment."